Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Nature Protocols|February 2, 2024
Comprehensive multiscale analysis of lactate metabolic dynamics in vitro and in vivo using highly responsive biosensorsAoxue Wang, Yejun Zou, Shuning Liu, et al.
Cellular & Molecular Immunology|October 11, 2022
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concernJingyi Yang, Mei-Qin Liu, Lin Liu, et al.
Cell Reports|July 21, 2021
A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variantBali Zhao, Jingyi Yang, Bing He, et al.
NPJ Vaccines|February 20, 2026
A modular three in one mucosal vaccine against three antigenic clusters of ACE2 using sarbecovirusesLin Liu, Haofeng Lin, Min Li, et al.
Signal Transduction and Targeted Therapy|August 31, 2021
VAV2 is required for DNA repair and implicated in cancer radiotherapy resistanceWeiling Liu, Chuanwang Miao, Shaosen Zhang, et al.
Emerging Microbes & Infections|March 27, 2026
A potent Gc neutralizing antibody reveals architecture-dependent bispecific protection against SFTSVHongjie Lu, Liushuai Li, Nan Zhang, et al.
Signal Transduction and Targeted Therapy|April 27, 2024
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1Xian Li, Mengxin Xu, Jingyi Yang, et al.
Antiviral Research|January 19, 2025
IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibilityMengxin Xu, Zhaoyong Zhang, Yuzhu Sun, et al.
Emerging Microbes & Infections|July 28, 2022
Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencingBing He, Shuning Liu, Mengxin Xu, et al.
Nature Communications|August 2, 2025
Broad neuraminidase antibodies confer protection against seasonal and avian influenza virusesKexin Lv, Xiaoman Li, Xingchen Zhu, et al.
Pageof 10